China National Accord Medicines Corporation Ltd. (SHE: 000028)
China flag China · Delayed Price · Currency is CNY
27.77
-0.55 (-1.94%)
Jan 3, 2025, 3:04 PM CST

China National Accord Medicines Corporation Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
1,4751,5991,4871,3361,4021,268
Upgrade
Depreciation & Amortization
1,3901,3901,3071,2421,035799.66
Upgrade
Other Amortization
199.23199.23180.31188.65158.89127.44
Upgrade
Loss (Gain) From Sale of Assets
-44.67-44.67-6.26-2.7-5.57-2.34
Upgrade
Asset Writedown & Restructuring Costs
-0.01-0.0155.64236.840.08-
Upgrade
Loss (Gain) From Sale of Investments
15.1615.16-28.87--1.86
Upgrade
Provision & Write-off of Bad Debts
71.3671.3629.7744.2221.234.77
Upgrade
Other Operating Activities
246.33306.59357.4131.94256.33225.93
Upgrade
Change in Accounts Receivable
-3,992-3,9921,227-2,121-2,990-793.31
Upgrade
Change in Inventory
-170.13-170.13-217.84-1,260-406.38-511.44
Upgrade
Change in Accounts Payable
3,6883,688-1,9492,1352,1251,010
Upgrade
Change in Other Net Operating Assets
-79.9-79.9193.22-203.6-81.3-119.94
Upgrade
Operating Cash Flow
2,7532,9372,5601,6551,5032,013
Upgrade
Operating Cash Flow Growth
39.87%14.71%54.69%10.14%-25.34%52.17%
Upgrade
Capital Expenditures
-301.2-322.21-322.19-370.43-293.83-251.86
Upgrade
Sale of Property, Plant & Equipment
36.5537.884.941.028.575.31
Upgrade
Cash Acquisitions
-71.4--126.35-109.95-2,646-97.8
Upgrade
Divestitures
-5.78-2.55---0.79
Upgrade
Investment in Securities
3.73-3.7289.66-144.03-31.09-56
Upgrade
Other Investing Activities
195.92155.1611.12167.86179.21175.25
Upgrade
Investing Cash Flow
-142.18-135.43-342.82-455.53-2,783-221.13
Upgrade
Short-Term Debt Issued
---81.45160.7-
Upgrade
Long-Term Debt Issued
-1,8771,520932.68857.52286.14
Upgrade
Total Debt Issued
1,5791,8771,5201,0141,018286.14
Upgrade
Short-Term Debt Repaid
---72.45-65.7-362.3-
Upgrade
Long-Term Debt Repaid
--3,061-2,629-2,100-1,700-924.72
Upgrade
Total Debt Repaid
-3,210-3,061-2,701-2,165-2,063-924.72
Upgrade
Net Debt Issued (Repaid)
-1,631-1,184-1,181-1,151-1,044-638.58
Upgrade
Issuance of Common Stock
31.631.6----
Upgrade
Common Dividends Paid
-545.06-559.07-574.19-610.54-549.91-493.06
Upgrade
Other Financing Activities
-234.93-696.11247.65-109.86-146.1131.42
Upgrade
Financing Cash Flow
-2,379-2,408-1,508-1,872-1,740-1,000
Upgrade
Foreign Exchange Rate Adjustments
-1.2-0.94-1.190.39-0.05-0.18
Upgrade
Net Cash Flow
230.17393.12708.66-671.6-3,021791.14
Upgrade
Free Cash Flow
2,4522,6152,2381,2851,2091,761
Upgrade
Free Cash Flow Growth
48.06%16.83%74.22%6.27%-31.34%65.00%
Upgrade
Free Cash Flow Margin
3.25%3.46%3.05%1.88%2.03%3.34%
Upgrade
Free Cash Flow Per Share
4.394.704.022.312.173.16
Upgrade
Cash Interest Paid
----20.148.12
Upgrade
Cash Income Tax Paid
1,8141,8871,7821,5641,4981,278
Upgrade
Levered Free Cash Flow
1,665837.242,410135.8-16.632,869
Upgrade
Unlevered Free Cash Flow
1,830992.482,573315.83144.743,042
Upgrade
Change in Net Working Capital
658.321,74228.072,0141,967-1,295
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.